News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Investor
Bellicum Pharmaceuticals, Inc. Prices Initial Public Offering Of 7,350,000 Shares Of Common Stock 12/18/2014
Biotech Predictions for Large Cap Firms Include Medivation, Inc. (MDVN), Gilead Sciences, Inc. (GILD) 12/18/2014
Xenetic Biosciences CEO Delivers “2014 – The Year In Review” Update To Investors And Stakeholders 12/18/2014
Xenetic Biosciences CEO Delivers “2014 – The Year In Review” Update To Investors And Stakeholders 12/18/2014
CytoSorbents, Inc. Receives NASDAQ Listing Approval 12/18/2014
Cara Therapeutics, Inc. (CARA) Announces Addition To The NASDAQ Biotechnology Index 12/18/2014
Trillium Therapeutics Inc. To List Common Shares On The NASDAQ Capital Market Under The Symbol TRIL 12/18/2014
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 12/18/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Completes Public Offering of Common Stock 12/18/2014
2015 Could Be Blockbuster Year for Alkermes plc (ALKS), Says Citi 12/17/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 12/17/2014
Novogen Limited (NVGN) Raises A$4.1 Million In Private Placement To US Institutions 12/17/2014
IGI Laboratories, Inc. Announces Closing Of $125 Million Of 3.75% Convertible Senior Notes Due 2019 12/17/2014
LifeSci Index Partners, LLC Release: BioShares Launches Two New Biotechnology ETFs (Nasdaq: BBC, BBP) 12/17/2014
Flexion Therapeutics (FLXN) Announces Exercise Of Underwriters' Over-Allotment Option And Closing Of Public Offering Of Common Stock 12/17/2014
SAGE Therapeutics Added To NASDAQ Biotechnology Index 12/17/2014
Relypsa, Inc. (RLYP) To Be Added To NASDAQ Biotechnology Index 12/17/2014
Alder Biopharmaceuticals Inc. Announces Addition To NASDAQ Biotechnology Index 12/17/2014
Agios Pharmaceuticals (AGIO) Announces Closing Of Public Offering And Full Exercise Of Over-Allotment Option 12/17/2014
Lion Biotechnologies, Inc. Announces Pricing Of Underwritten Common Stock Offering 12/17/2014
Eli Lilly (LLY) Sets Dates And Conference Calls For 2015 Financial Guidance And Fourth-Quarter 2014 Financial Results 12/16/2014
The Biotech Year in Review, According To Bernstein 12/16/2014
Easton Pharmaceuticals (OP: EAPH) Releases Preliminary Vaporizer Related Sales Of $25,638.00 In The Month Of November 12/16/2014
Pfizer (PFE) Declares First-Quarter 2015 Dividend 12/16/2014
bluebird bio (BLUE) Announces Proposed Public Offering Of Common Stock 12/16/2014
Retrophin (RTRX) Announces Addition To The NASDAQ Biotechnology Index 12/16/2014
EXACT Sciences Corporation (EXAS) Announces Agreement To Sell 4,000,000 Common Shares 12/16/2014
Aerie Pharmaceuticals, Inc. (AERI) Added To NASDAQ Biotechnology Index (NBI) 12/16/2014
Foundation Medicine, Inc. (FMI) To Be Added To NASDAQ Biotechnology Index 12/16/2014
K-Bro Declares December Dividend 12/16/2014
Eli Lilly (LLY) Announces Dividend Increase 12/16/2014
Crescendo Biologics' Receives Further Investment From Astellas Venture Management To Develop Novel Humabody Therapeutics Targeting Immune Checkpoint Inhibitors 12/16/2014
Glucose Health, Inc. To Upgrade To OTCQB Venture Market 12/16/2014
Alimera Sciences (ALIM) Added To NASDAQ Biotechnology Index 12/16/2014
Valeant (VRX) To Hold Conference Call To Announce 2015 Financial Guidance 12/16/2014
Kite Pharma, Inc. (KITE) Added To The NASDAQ Biotechnology Index 12/16/2014
Celladon Corporation Added To NASDAQ Biotechnology Index 12/16/2014
QLT Inc. (QLTI) Announces Results Of Annual General Meeting Of Shareholders 12/16/2014
Flamel Technologies (FLML) To Be Included In NASDAQ Biotech Index 12/15/2014
Akebia Therapeutics, Inc. (AKBA) Added To NASDAQ Biotechnology Index 12/15/2014
Acceleron Pharma Added To NASDAQ Biotechnology Index 12/15/2014
TetraPhase Pharmaceuticals Added To NASDAQ Biotechnology Index 12/15/2014
Enanta Pharmaceuticals, Inc. Added To The NASDAQ Biotechnology Index 12/15/2014
Ophthotech Corporation (OPHT) Added To NASDAQ Biotechnology Index 12/15/2014
Concert Pharmaceuticals, Inc. (CNCE) To Be Added To NASDAQ Biotechnology Index 12/15/2014
Acceleron Pharma Added To NASDAQ Biotechnology Index 12/15/2014
TetraPhase Pharmaceuticals Added To NASDAQ Biotechnology Index 12/15/2014
Enanta Pharmaceuticals, Inc. Added To The NASDAQ Biotechnology Index 12/15/2014
BioTime (BTX) To Host Investor And Analyst Day On December 15, 2014 12/15/2014
The NASDAQ OMX Group, Inc. Today Announced That Radius (RDUS) Will Be Added To Its Biotechnology Index Effective Before Market Open On Monday, December 22, 2014 12/15/2014
Karyopharm Therapeutics (KPTI) Announces Addition To The NASDAQ Biotechnology Index 12/15/2014
KYTHERA Biopharmaceuticals, Inc. (KYTH) Grants Stock Options Under Inducement Program 12/15/2014
Inovio Pharmaceuticals (INO) Added To NASDAQ Biotechnology Index 12/15/2014
ZS Pharma (ZSPH) To Ring The Nasdaq Stock Market Opening Bell 12/15/2014
iBio, Inc. (IBIO) Provides Updates On Its IBIO-CFB03 Fibrosis Drug Candidate And Other Activities For The 2014 Annual Shareholders Meeting 12/12/2014
EPIRUS Biopharmaceuticals Seeks British Columbia Securities Commission Order That It Is No Longer A Reporting Issuer 12/12/2014
SYGNIS AG Successfully Completes Rights Offering And Private Placement 12/12/2014
OvaScience (OVAS) To Host Investor Day 12/12/2014
Centene Corporation Announces 2015 Guidance And Confirms 2014 Guidance 12/12/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Announces Pricing Of Public Offering Of Common Stock 12/12/2014
Great Basin Corporation Schedules Product Roadmap Update Call And Webcast 12/12/2014
Auxilium Pharmaceuticals (AUXL) Announces Date For Special Meeting Of Stockholders 12/12/2014
Endo International (ENDP) Registration Statement Relating To Pending Auxilium Pharmaceuticals (AUXL) Acquisition Declared Effective By The SEC 12/12/2014
Rock Creek Pharmaceuticals Announces Listing Extension On NASDAQ 12/12/2014
Anavex Life Sciences Corp. (AVXL.OB) Upgrades To OTCQX Marketplace 12/12/2014
Flexion Therapeutics (FLXN) Announces Pricing Of Public Offering Of Common Stock 12/12/2014
Intuitive Surgical, Inc. (ISRG) Reports New Employee Option Grants For December 2014 12/12/2014
ContraVir Pharmaceuticals' CEO Issues Letter To Shareholders Highlighting Significant Progress 12/11/2014
China Cord Blood Corporation Announces Results of 2014 Annual General Meeting 12/11/2014
Trevena, Inc. (TRVN) Announces Closing Of Public Offering And Partial Exercise Of Underwriters’ Option To Purchase Additional Shares 12/11/2014
Kite Pharma, Inc. (KITE) Announces Pricing Of Follow-On Offering 12/11/2014
Agios Pharmaceuticals (AGIO) Announces Pricing Of $220 Million Public Offering Of Common Stock 12/11/2014
IGI Laboratories, Inc. Announces Pricing Of $125 Million Of 3.75% Convertible Senior Notes Due 2019 12/11/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Announces $45 Million Proposed Public Offering 12/11/2014
Valeant (VRX) To Drop Deal-Making To Cut Debt, Boost Stock 12/10/2014
Analysts Not Sold On Medivation, Inc. (MDVN)’s Xtandi as Breast Cancer Drug 12/10/2014
Agios Pharmaceuticals (AGIO) Announces Proposed Offering Of Common Stock 12/10/2014
Galapagos NV (GLPG.BR) Increases Share Capital Through Warrant Exercises 12/9/2014
bluebird bio (BLUE)’s New Blood Treatment Could Benefit Sickle Cell, Says Analyst 12/9/2014
Swedish Orphan Biovitrum CEO Geoffrey McDonough Sells A Portion Of 2014 Incentive Shares 12/9/2014
IntelGenx Corp. Grants Stock Options 12/9/2014
XOMA (US) LLC (XOMA) Announces Pricing Of $40.0 Million Registered Offering Of Common Stock And Warrants 12/9/2014
Edwards Lifesciences (EW) Outlines Growth Strategy At Annual Investor Conference 12/8/2014
Survey of Investors, Hedge Funds Blasé on Merck & Co. (MRK), Cubist Pharmaceuticals, Inc. (CBST) Deal 12/8/2014
Karolinska Development AB Release: Purchase Of Own Shares To Cover Social Security Fees Related To Incentive Program 12/8/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 12/8/2014
Becton, Dickinson and Company (BDX) And CareFusion Corporation Announce Date Of Special Meeting In Proposed Merger 12/8/2014
Onconova Therapeutics Inc. (ONTX) To Host Analyst Event In New York City On December 12, 2014 12/8/2014
CytoSorbents, Inc. Reports Temporary Change Of Stock Trading Symbol 12/8/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 12/5/2014
GlaxoSmithKline (GSK) Abandons Planned Sale Of Established Products Portfolio 12/5/2014
Trevena, Inc. (TRVN) Announces Pricing Of Public Offering 12/5/2014
Drug Spending Still Under 10% of American Health Costs, Says Analyst 12/5/2014
Champions Oncology, Inc. (CSBR) Closes Convertible Debt Financing 12/5/2014
ANI Pharmaceuticals, Inc. Announces Pricing Of Upsized $125 Million Convertible Notes Offering 12/5/2014
Rubicon Hints At ArborGen IPO, Laments Skidding Share Price 12/5/2014
Cortendo AB Formally Informs Oslo Børs That It Will Not Pursue Oslo Axess Listing 12/5/2014
OncoSec Medical Inc. To Host Corporate Update Conference Call On December 9, 2014 12/5/2014
Innate Pharma (IPH.PA ) Announces Its 2015 Financial Calendar As Well As Its Participation In Upcoming Investor Conferences 12/5/2014
StemCells Inc. (STEM) Hosts Leading Biotech Investors And Analysts At Inaugural Event 12/5/2014
Immunomedics, Inc. (IMMU) Announces Outcome Of 2014 Annual Meeting Of Stockholders 12/5/2014
Corium International, Inc. Announces Closing Of Expanded Term Loan Facility With CRG 12/5/2014
BioMarin Pharmaceutical Inc. (BMRN) To Host Analyst And Investor Day On December 10th In New York 12/5/2014
Cryo-Cell International (CCEL) Adopts Three-Year Stockholder Rights Plan 12/5/2014
Tute Genomics Raises $2.3 Million To Scale Up Cloud-Based Genome Analytics And Accelerate Personalized Medicine 12/5/2014
Henry Schein, Inc. (HSIC) Announces $300 Million Increase To Share Repurchase Plan 12/5/2014
PDL BioPharma, Inc. (PDLI) Announces Conversion Rate Adjustments For Convertible Notes 12/4/2014
Becton, Dickinson and Company (BDX) To Offer Senior Unsecured Notes 12/4/2014
ANI Pharmaceuticals, Inc. Announces $100 Million Public Offering Of Convertible Notes 12/4/2014
BTG plc (BTG.L) Results Of Placing 12/4/2014
WuXi PharmaTech Co., Ltd. Subsidiary Submits Application To The National Equities Exchange And Quotations In China To List On The New Third Board 12/4/2014
Was Your Company Hacked? Biotech Firms Rush To Deny FIN4 Breach 12/3/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data 12/3/2014
Is New Alzheimer’s Drug the Stabilizing Force Biogen Idec (BIIB) Needs? 12/3/2014
West Pharmaceutical Services Provides Required Notice Of Automatic Conversion Of Debentures 12/3/2014
Vivione Biosciences Engages Ardour Capital As Its Exclusive Investment Banker 12/3/2014
Ocata Therapeutics Announces Proposed Underwritten Offering of Common Stock 12/3/2014
ChromaDex, Inc. Receives $750,000 Cash From Previous Sale Of Its Bluscience Line 12/3/2014
DelMar Pharmaceuticals Joins OTCQX 12/3/2014
Perrigo Company (PRGO) Announces The Closing Of Its Registered Public Offering Of Senior Notes 12/3/2014
Abbott Laboratories (ABT) Attracts Bullish Trades 12/3/2014
Covidien plc (COV) Release: Announcement Under Irish Takeover Rules Relevant Securities In Issue - December 3, 2014 12/3/2014
Enzo Biochem (ENZ) Schedules Teleconference To Discuss First Quarter Results Wednesday, December 10, 2014 At 8:30 AM E.T. 12/3/2014
Race Heats Up for Best Hair in Biopharma Contest As Celgene (CELG), Acorda Therapeutics (ACOR) Square Off 12/2/2014
Can-Fite BioPharma (CFBI) Announces $8 Million At-The-Market Registered Direct Offering 12/2/2014
Teva Pharmaceutical Industries Limited (TEVA) To Host 2015 Business Outlook Conference Call And Webcast On December 11, 2014 12/2/2014
Celgene (CELG) Recommends Shareholders Reject "Mini-Tender" Offer By TRC Capital Corporation 12/2/2014
Medgenics, Inc. Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Option To Purchase Additional Shares Of Common Stock 12/2/2014
Shire To Highlight Pipeline Progress And Breadth Of Innovative Portfolio In R&D Day 12/2/2014
Tekmira (TKMR) Files Shelf Registration Statement 12/1/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) To Host Analyst And Investor Event 12/1/2014
Affymax, Inc. (AFFY) Adopts Tax Benefit Preservation Plan To Protect Net Operating Loss Carryforwards 12/1/2014
Number Of Outstanding Shares In Elekta AB (SE:EKTAB) 12/1/2014
Extraordinary General Meeting In Cortendo AB 12/1/2014
Nanobiotix Places Shares And Warrants With U.S. Investor 12/1/2014
Valeant (VRX) Announces Redemption Of US$445.0 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018 12/1/2014
Cowen: With NASDAQ Index Up 33%, Biotech Remains a Winner 12/1/2014
2015 Will Be A Defining Year for Gene Therapy, Says Analyst 12/1/2014
Roche Holdings, Inc. Announces Final Results Of Its Debt Tender Offer 12/1/2014
Trevena, Inc. (TRVN) Announces Commencement Of Public Offering 12/1/2014
Axcelon Biopolymers Corp. Announces Closing Of Private Placement Financing In Its Woundcare Subsidiary 12/1/2014
Neothetics Announces Closing Of Upsized Initial Public Offering 12/1/2014
Affymax, Inc. (AFFY) Announces A Special Cash Distribution And The Appointment Of A New Director And Chief Executive Officer 12/1/2014
Kite Pharma, Inc. (KITE) Files Registration Statement For Proposed Follow-On Offering 12/1/2014
Immune Pharmaceuticals, Inc. Completes Underwriter's Exercise Of Partial Over-Allotment Option 12/1/2014
Valeant (VRX) Announces Redemption Of US$445.0 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018 12/1/2014
Ex-Retrophin (RTRX) CEO Sold Stock While Urging Investors To Buy 11/26/2014
Medgenics, Inc. Prices Public Offering of Common Stock 11/26/2014
University of New Hampshire Research Finds Growth In U.S. Angel Investor Market; Decrease In Deal Size 11/26/2014
Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 11/26/2014
NEMUS Bioscience Is Now Quoted On The OTC Bulletin Board Under The Ticker Symbol Of "NMUS" 11/26/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) To Host Annual Meeting Of Stockholders 11/26/2014
Immune Pharmaceuticals, Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 11/26/2014
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At The NASDAQ OMX 31st Investor Program 11/26/2014
Cynapsus Therapeutics (CYNAF) Announces Uplisting To The Toronto Stock Exchange’s Senior Equity Market 11/26/2014
Catalyst Pharmaceuticals (CPRX) CEO Outlines Biotech's 5 Phases Of Risk 11/25/2014
Investors Expect Record Year for Biotech Venture Capital 11/25/2014
Sarepta Therapeutics (SRPT) To Host Webcast And Conference Call For The Duchenne Muscular Dystrophy Community On December 2, 2014 11/25/2014
Analyst: First Quarter of 2015 Crucial to ProSensa Holding N.V. (RNA), BioMarin Pharmaceutical Inc. (BMRN) Deal 11/25/2014
Merck & Co. (MRK) Announces Increased Quarterly Dividend 11/25/2014
Rockwell Medical (RMTI) Closes $58.5 Million Public Offering Of Common Stock 11/25/2014
Becton, Dickinson and Company (BDX) Board Declares Dividend 11/25/2014
Receptos (RCPT) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares And Completion Of Underwritten Public Offering Of Common Stock 11/25/2014
Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance plc 11/25/2014
Becton, Dickinson and Company (BDX) And CareFusion Corporation Announce Expiration Of HSR Act Waiting Period In Proposed Transaction 11/25/2014
BioMarin Pharmaceutical Inc. (BMRN), ProSensa Holding N.V. (RNA) Marriage Makes Sense for Investors If Regulatory Hurdles Can Be Overcome 11/24/2014
AVANIR Pharmaceuticals (AVNR) Making Strides With Alzheimer’s Drug, Says Analyst 11/24/2014
Amicus Therapeutics, Inc. (FOLD) Announces Closing Of Underwritten Offering Of Common Stock And Full Exercise Of Over-Allotment Option 11/24/2014
CollabRx, Inc. Announces Receipt Of NASDAQ Notice Of Bid Price Deficiency 11/24/2014
Conatus Pharmaceuticals Inc. To Present At Two December Investor Conferences 11/24/2014
Medgenics, Inc. Announces Public Offering of Common Stock 11/24/2014
Bayer AG (BAYZF) To Use IPO Funds To Cut Debt And Buy Consumer Drugs 11/24/2014
Tekmira (TKMR) Provides Key Highlights Of Analyst And Investor Day In New York 11/24/2014
Proteon Therapeutics, Inc. (PRTO) Announces The Closing Of Initial Public Offering And The Underwriters' Option To Purchase Additional Shares 11/24/2014
PlasmaTech Biopharmaceuticals, Inc. Announces Stock Ticker Symbol Change To PTBI 11/24/2014
OnCore Biopharma Announces Confidential Submission Of Draft Registration Statement For Initial Public Offering 11/24/2014
Marrone Bio Innovations, Inc Receives NASDAQ Notice Regarding Late Form 10-Q Filing 11/24/2014
Perrigo Company plc Announces Underwriters' Full Exercise Of Option To Purchase Ordinary Shares In Connection With The Equity Offering 11/24/2014
Perrigo Company plc Announces Proposed Public Offering Of Senior Notes Of Its Finance Subsidiary, Perrigo Finance plc 11/24/2014
Solid Lymphoma Data Points To Larger Potential For Epizyme (EPZM), Says Citi 11/21/2014
EXCLUSIVE: Ackman Says “Biggest Mistake” In Allergan (AGN) Bid Was Tender Offer 11/21/2014
Neovacs SA Secures A New Equity Line Financing With Kepler Cheuvreux 11/21/2014
Agilent Technologies Inc. (A) Announces Cash Dividend Of 10 Cents Per Share 11/21/2014
Lexicon Pharmaceuticals, Inc. (LXRX) Announces Pricing Of Common Stock Offering 11/21/2014
Perrigo Company Plc Announces The Pricing Of Its Offering Of Ordinary Shares 11/21/2014
Cytori Therapeutics, Inc. (CYTX) To Provide Corporate Update And Investor Presentation On December 4 Through A Live, Interactive Webcast 11/21/2014
Cowen: Acorda Therapeutics (ACOR) Not Worried About Civitas Therapeutics' New Parkinson's Drug 11/20/2014
MYOS (MYOS) Announces $1.81 Million Registered Direct Offering 11/20/2014
Matinas BioPharma To Present At Two Investor Conferences In Early December 11/20/2014
StemCells Inc. (STEM)To Host Inaugural Investor And Analyst Event In New York 11/20/2014
ZS Pharma (ZSPH) Hosts And Webcasts Investor Event 11/20/2014
Aequus Pharmaceuticals Closes $4.2 Million Private Placement Financing 11/20/2014
Valeant (VRX) Announces New $2 Billion Securities Repurchase Program 11/20/2014
Cipher Pharmaceuticals (DND.TO) To Commence Trading On The NASDAQ Global Market 11/20/2014
Immune Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock 11/20/2014
Organovo Holdings, Inc. To Provide Corporate Update And Investor Presentation In A Live, Interactive Webcast On December 4 11/20/2014
Perrigo Company plc Announces Proposed Public Offering Of Ordinary Shares 11/20/2014
Rockwell Medical (RMTI) Prices $58.5 Million Public Offering Of Common Stock 11/20/2014
LentiGlobin Looks Promising On Sickle Cell For bluebird bio (BLUE), Says Analyst 11/19/2014
Daxor Corporation (DXR) Announces Payment Of A Dividend 11/19/2014



//-->